Atorvastatin calcium and Calcinosis - a phase IV clinical study of FDA data

Summary:

Calcinosis is reported as a side effect among people who take Atorvastatin calcium (atorvastatin calcium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Pain.

The phase IV clinical study analyzes which people have Calcinosis when taking Atorvastatin calcium. It is created by eHealthMe based on reports of 72,753 people who have side effects when taking Atorvastatin calcium from the FDA, and is updated regularly.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,289 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

What is Calcinosis?

Calcinosis (calcium deposits in any soft tissue) is found to be associated with 487 drugs and 857 conditions by eHealthMe. Check the latest studies of Calcinosis.

On Mar, 18, 2026

72,753 people reported to have side effects when taking Atorvastatin calcium.
Among them, 12 people (0.02%) have Calcinosis.

Could Atorvastatin calcium cause Calcinosis?

Among these 12 people:

How long have people been on Atorvastatin calcium when they have Calcinosis? *

What is the gender of people who have Calcinosis when taking Atorvastatin calcium? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Calcinosis when taking Atorvastatin calcium? *

What are other drugs people take besides Atorvastatin calcium? *

Aspirin: 3 people, 25.00%
Metoprolol Tartrate: 2 people, 16.67%
Hydrocodone: 2 people, 16.67%
Zyrtec: 1 person, 8.33%
Duloxetine Hydrochloride: 1 person, 8.33%
Lantus: 1 person, 8.33%
Glimepiride: 1 person, 8.33%
Fenofibrate: 1 person, 8.33%
Evista: 1 person, 8.33%
Coenzyme Q10: 1 person, 8.33%

What are other side effects people have besides Calcinosis? *

Atherosclerosis (disorder of the arteries): 2 people, 16.67%
Drug Hypersensitivity: 2 people, 16.67%
Blood Urine Present: 2 people, 16.67%
Mitral Valve Incompetence (inefficient heart valve): 2 people, 16.67%
Bladder Pain: 2 people, 16.67%
Nephrocalcinosis (a condition in which calcium levels in the kidneys are increased): 2 people, 16.67%
Calculus Bladder (bladder stone): 2 people, 16.67%
Renal Disorder (kidney disease): 2 people, 16.67%
Intervertebral Disc Disorder (spinal disc disorder): 2 people, 16.67%
Gynecomastia (enlargement of the gland tissue of the male breast): 2 people, 16.67%

What are the existing conditions these people have? *

Pain: 2 people, 16.67%
Renal Cell Carcinoma (a kidney cancer): 1 person, 8.33%
Prostate Cancer: 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Diabetes: 1 person, 8.33%
Blood Testosterone Decreased: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Atorvastatin calcium and have Calcinosis?

- Check whether Calcinosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atorvastatin calcium:

Atorvastatin calcium (77,289 reports)

Calcinosis treatments and more:

Calcinosis (3,651 reports)

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Calcinosis:

Calcinosis (487 drugs)

Browse all the conditions that are associated with Calcinosis:

Calcinosis (857 conditions)

Related publications that referenced our studies

Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Atorvastatin calcium) and Atorvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.